Delivery Order SPE2DB22D2206-SPE2DB24FHX32

Award Date 6/25/24
Potential Completion Date 7/17/24
Potential Value $44K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a $7,322.67 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide IMBRUVICA 420 MG TABLET 28S. This order is a part of Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The IDC, which does not have a set-aside designation,...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $14,645.34 to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of Imbruvica 420 mg tablets, a prescription medication. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a wide range of...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order valued at $7,322.67 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The order is for the supply of 420 mg Imbruvica tablets, a prescription medication, with a completion date of July 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $7,322.67 for the provision of IMBRUVICA 280 MG TABLET 28S. The contract is a firm fixed price agreement with the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564994962 IMBRUVICA 420 MG TABLET 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $7,322.67, is a Firm Fixed Price Delivery Order with a completion date of July 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, involves the delivery of IMBRUVICA 140 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price delivery order, valued at $23,537.16, has an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
This is a $7,322.67 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corporation's Corporate Office Division. The order is for 4,564,522,930 units of the pharmaceutical product IMBRUVICA 420 MG Tablet 28S. The contract has a completion date of May 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,645.34, is for the delivery of IMBRUVICA 280 MG tablets. It is a firm-fixed-price delivery order contract with a completion date of November 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,575.75 Firm Fixed Price Delivery Order contract is for the provision of the drug IMBRUVICA 280 MG TABLET 28S. The contract has an ultimate completion date of March 10, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a $7,322.67 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The order is for the pharmaceutical product Imbruvica 280 mg Tablet, 28s, and has a firm-fixed price. The contract has an ultimate completion date of October 21, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by the DLA and other agencies to provide a...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FHX32
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the prescription drug IMBRUVICA 420 MG TABLET 28S to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The $43,936.02 firm-fixed price delivery order has a completion date of July 17, 2024.

Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. Additionally, Amerisourcebergen has a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. The contract does not have a set-aside designation.

Generated 9/24/24, 9:28 AM